Label Changes for:

Diovan (Valsartan) Tablets

August 2012

Changes have been made to the CONTRAINDICATIONS, WARNINGS, PRECAUTIONS and ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – June and December 2011, February and August 2012

 

August 2012

 

CONTRAINDICATIONS

  • Do not use in patients with known hypersensitivity to any component
 
Advertisement
Close

Recommended

(web6)